BioHarvest Sciences Inc. - Common Stock (BHST)

2.7700
-0.0100 (-0.36%)
NASDAQ· Last Trade: Jul 13th, 7:47 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
BioHarvest Sciences to Participate in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - July 13, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a...
Via Newsfile · July 13, 2026
Q2 Investor Summit Virtual Live Wednesday June 24
NEW YORK, NY / ACCESS Newswire / June 23, 2026 / The Investor Summit today announced the lineup of public companies scheduled to present at its upcoming Virtual June 24-25, 2026 event.
By Investor Summit Group · Via ACCESS Newswire · June 23, 2026
BioHarvest Sciences to Present at the 2026 BIO International Convention
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 18, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a...
Via Newsfile · June 18, 2026
Tate & Lyle Expands Collaboration with BioHarvest Sciences to Accelerate Next-Generation Sweetener Innovation
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 18, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0), a...
Via Newsfile · May 18, 2026
BioHarvest Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
Quarterly revenue up 8% year over year; Annual revenue guidance range remains at $42-$48 million CDMO fragrance and Saffron...
Via Newsfile · May 14, 2026
BioHarvest Sciences Appoints New Head of Business Development for its CDMO Division
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 13, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...
Via Newsfile · May 13, 2026
BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications
- CDMO program advances to Stage 2 of development agreement valued at $1.125 million-Advancement of sustainable solution for the production...
Via Newsfile · May 13, 2026
BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform
Source plant is widely regarded as one of the most valuable fragrance raw materials in the worldStage 2 contract follows...
Via Newsfile · May 12, 2026
BioHarvest Sciences to Report First Quarter 2026 Financial Results on May 14, 2026
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - April 30, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...
Via Newsfile · April 30, 2026
BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy
Ilan Sobel joins Board of Directors with focused mandate on D2C growth.Dr. Zaki Rakib, Co-Founder and Executive Chairman, assumes role...
Via Newsfile · April 29, 2026
BioHarvest Sciences Reports Fourth Quarter and Full-Year 2025 Financial Results
FY2025 Revenues were $34.5 million, up 37% vs previous year.The VINIA brand has achieved the No.1 resveratrol polyphenol...
Via Newsfile · March 31, 2026
BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 31, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...
Via Newsfile · March 31, 2026
BioHarvest Sciences Announces that VINIA is Now the No.1 Resveratrol Polyphenol Brand in the United States
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 26, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the...
Via Newsfile · March 26, 2026
BioHarvest Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 17, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or...
Via Newsfile · March 17, 2026
BioHarvest Sciences Announces Board Transition and Appointment of Prof. Hezi Levy
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 5, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) ("BioHarvest" or the...
Via Newsfile · March 5, 2026
BioHarvest Sciences to Participate in 38th Annual Roth Conference on March 22-24, 2026
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 3, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) ("BioHarvest" or the "Company"), a...
Via Newsfile · March 3, 2026
BioHarvest Sciences Issues Year End Shareholder Letter
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 7, 2026) - BioHarvest Sciences Inc., (NASDAQ: BHST) (FSE: 8MV0)...
Via Newsfile · January 7, 2026
BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 18, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or...
Via Newsfile · December 18, 2025
BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product
First Hydration Formula Powered by VINIA's Blood Flow Technology Enters the $13 Billion U.S. Electrolyte MarketVancouver, British Columbia and Rehovot,...
Via Newsfile · December 3, 2025
BioHarvest Sciences Reports Third Quarter 2025 Financial Results
Company Fortifies Balance Sheet with Recent $19.9 Million Instiutional Equity Raise Following $14.7 Million Strengthening of Balance Sheet via ...
Via Newsfile · November 13, 2025
BioHarvest Sciences to Attend the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 12, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...
Via Newsfile · November 12, 2025
BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter's Option to Purchase Additional Shares
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 10, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...
Via Newsfile · November 10, 2025
BioHarvest Sciences Announces Pricing of $17.4 Million Upsized Public Offering of Common Stock
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 7, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...
Via Newsfile · November 7, 2025
BioHarvest Announces Proposed Public Offering of Common Stock
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 6, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...
Via Newsfile · November 6, 2025
BioHarvest Sciences to Host Third Quarter Earnings Call on November 13 at 4:30 p.m. Eastern Time
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 4, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...
Via Newsfile · November 4, 2025